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Results: DER and SER increase as the distance of the GNPs 
reduces. The largest DER as well as SER was obtained for 0.25 
× 0.25 × 0.25 μm³ cube for 100 nm 0.18 × 0.18 × 0.18 μm³ for 
50 nm GNP. In case of 50 nm GNPs, DER increment was 1.421, 
1.396, 1.017, and 1.014 for 50 kVp, 100 kVp photons, 70 MeV 
and 170 MeV protons, respectively. SER increment was 1.319, 
1.303, 1.021, and 1.018, for 50 kVp, 100 kVp photons, 70 MeV 
and 170 MeV protons, respectively. For 100 nm GNPs, we 
observed the qualitatively same results but increment ratio 
was larger for all tested radiations. 
 
Conclusion: As shown in this study, DER with GNPs was larger 
when they are closely packed in the phantom. Therefore, 
better therapeutic effects can be expected with close-packed 
GNPs. 
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Purpose or Objective: To investigate the feasibility of using 
multifunctional Fe3O4/TaOx (core / shell) nano particles 
developed for CT and MRI contrast agent as dose enhancing 
radiosensitizers.  
 
Material and Methods: Firstly, to verify the imaging 
detectability of Fe3O4/TaOx nano particles, in-vivo tests 
were conducted. Approximately 600 mg/kg of19 nm diameter 
Fe3O4/TaOx nano particles dispersed in phosphate buffered 
saline (PBS) were injected to ten nude Balb/c mice through 
the tail vein. Mico-CT (Simens Inveon) was scanned for 5 mice 
and MRI (BioSpec, 70/20 USR, BRUKER Co.) scan was 
conducted for rest of mice. For both imaging, 4 consecutive 
scanning was performed at pre- and post-injection (5 min, 30 
min, and 1 hour). Difference between pre- and post-injection 
images was analyzed by computing the pixel histogram and 
correlation coefficient factor using MATLAB in the user 
defined ROI (region of interests) . Secondly, to quantify the 
potential therapeutic enhancement with nano materials, DER 
(Dose Enhancement Ratio) and number of SER (Secondary 
Electron Ratio) were computed using MC simulation (TOPAS 
v.b-12). Diameter of 19 nm circular beams of mono-energetic 
10 MeV, 70 MeV, 150 MeV protons were irradiated to a 
Gold(Au), Tantalum(Ta), TaOx, Fe3O4/TaOx (core / shell), 
and Fe3O4 nano particle located at the center of 4 × 4 × 4 
μm³ water filled cube phantom. DER and SER were computed 
by placing a 1 nm thickness of shell detector at the surface of 
the particle. 
 
Results: In CT, MRI imaging, the aorta, the blood vessel, and 
the liver were clearly visualized after intravenous injection 
of Fe3O4/TaOx nano particles. There was large different 
between pre and post-injection images of Histogram data and 
Coefficients of correlation factor in CT and MR are 0.006, 
0.060, respectively. When 10 MeV protons were irradiated for 
a Gold(Au), Tantalum(Ta), TaOx, Fe3O4/TaOx, Fe3O4 nano 
particle, DER was 9.089, 7.724, 4.424, 3.660 and 3.255 
respectively. Similarly, SER increment was 9.629, 8.401, 
5.060, 4.341, and 3.590 for Gold(Au), Tantalum(Ta), TaOx, 
Fe3O4/TaOx, Fe3O4 nano particle, respectively. For 70 MeV 
proton beams, DER was similar to those for 10 MeV, but 




Conclusion: Fe3O4/TaOx nano particles have potential as a 
multifunctional agent which enhances the accuracy in cancer 
detection through visualization of developed tumor lesion 
and increases the therapeutic effect in proton therapy. The 
dose enhancement with Fe3O4/TaOx was estimated as half of 
the Gold. However, tumor targeting such as combined with 
magnetic field may overcome the low DER 
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Purpose or Objective: The goal of radiotherapy is to deliver 
into tumor volume certain amount of radiation to kill all 
tumor cells and at the same time to minimize radiation 
damage of surrounding healthy tissues. To reach the goal 
modern conventional radiotherapy uses multifield irradiation 
with beam changing its shape and intensity. However this 
approach is not efficient enough in case when healthy and 
tumor tissues are highly diffused with each other. In this case 
partial healthy tissues damage is inevitable. Yet another 
approach is possible. Using some physiological mechanism 
tumor can be saturated with a high atomic number element 
capable to interact with external radiation more likely than 
the elements of biological tissues. That leads to dose 
increase at the site of the element location. For that purpose 
such elements as iodine, gold etc. and external x-rays 
radiation of energy up to 600 keV can be used. The main 
obstacle in implementing that method is how to deliver 
necessary amount of a high atomic number element into a 
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tumor. Attempts of developing tumor targeting drug, which 
would be capable to deliver necessary amount of high atomic 
number element into the tumor haven’t succeed yet. Another 
possible way to deliver such elements into the tumor is to 
utilize some pathological processes caused by tumorogenesis 
such as blood barrier disruption in case of brain tumors or 
high vascularization inherent to some tumors. In this work 
the efficacy of x-rays irradiation with disodium 
gadopentetate (Gd-DTPA) administration in treating highly 
vascularized transplanted tumor in mice was studied. 
 
Material and Methods: C57Bl/6 mice with transplanted 
adencarcinoma Ca755 were used in the study. Animals were 
divided into three groups. 1st group undergo no treatment. 
2nd group was irradiated with 10 Gy of x-rays. Animals in 3rd 
group were administered with 0.3 ml of 0.5M water solution 
of Gd-DTPA, containing 23 mg of gadolinium and then 
irradiated as well. Administration of Gd-DTPA was performed 
with single systemic injection. Irradiation was performed 
using x-rays generator with anode voltage of 200 kV. 
Antineoplastic efficacy was estimated by measuring tumor 
volume and life span of mice. 
 
Results: Tumor growth rate plots are presented in Figure. 
 
Tumor growth delay for test group was 13 days whereas in 
irradiated control group tumor growth delay was just 4 days. 
Median life span was 22 days, 37 days and 46 days for control 
group, irradiated control group and test group respectively. 
In test group 25% of animals have full tumor regression 
whereas in both control groups no tumor regression was 
observed. Endpoints of antitumor evaluation, i.e. T/C% ratio 




Conclusion: Obtained results show that systemic injection of 
extracellular drug with gadolinium prior irradiation with x-
rays provide enough amount of gadolinium in highly 
vascularized tumors and lead to significant increase of 
antineoplastic efficacy of x-rays irradiation. 
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Purpose or Objective: With the development of molecular 
biology and gene engineering，more and more attention has 
been paid to gene-radiotherapy of malignant tumors. The 
combination of gene therapy and radiotherapy is regarded as 
one of the effective methods for the treatment of tumors. 
This research focused on the Egr-1 promoter with radiation-
induced effect, p53 and endostatin genes with function of 
inducing apoptosis and anti-angiogenesis, and EGFR-targeted 
adenovirus vector with higher cell infection efficiency. The 
therapeutic effect of adenovirus vectors Ad.Egr-wtp53-
endostatin and Ad.CMV-sCAR-EGF combined with 
radiotherapy in non-small cell lung cancer is here reported.  
 
Material and Methods: The adenovirus vectors Ad.Egr-wtp53-
endostatin containing both wild type p53 and antiangiogenic 
molecule endostatin genes downstream of early growth 
response-1 (Egr-1) and Ad.CMV-sCAR-EGF containing 
coxsackie virus receptor extracellular segment (sCAR) and 
epidermal growth factor (EGF) were constructed using gene 
recombination technique. The infection efficiency in non-
small cell lung cancer cell lines (A549, LK-2 and Lu65) of 
Ad.Egr-wtp53-endostatin mediated with Ad.CMV-sCAR-EGF 
expressed fusion protein sCAR-EGF was detected. The 
expression of wild type p53 and endostatin genes by the 
radiation-sensitive promoter Egr-1 in non-small cell lung 
cancer cell lines were observed. Immunodeficient mice 
(NOD/scid) subcutaneously implanted with A549 cells were 
treated by conventional radiotherapy (2Gy×6) and/or gene 
therapy (intratumor injection of adenovirus vectors Ad.Egr-
wtp53-endostatin and Ad.CMV-sCAR-EGF 24 h before the first 
and fourth local doses). Immunologic mechanisms were 
explored. 
 
Results: The fusion protein SCAR-EGF expressed from 
Ad.CMV-sCAR-EGF significantly increased infection efficiency 
of Ad.Egr-wtp53-endostatin in human non-small cell lung 
cancer cell lines. Cancer control was most significantly 
improved in the group receiving local radiotherapy combined 
with gene therapy as shown by prolongation of mean survival 
time by 75.2%, reduction in average tumor weight by 88.7%, 
decrease in pulmonary metastasis by 76.9% and decrease in 
intratumor angiogenesis by 80.4% as compared to local 
radiotherapy alone (P < 0.05). Immunologic studies showed 
stimulated natural killer (NK) and cytotoxic T lymphocyte 
(CTL) activity as well as increased interferon-γ (IFN- γ) and 
tumor necrosis factor-α (TNF-α) secretion in this combined 
treatment group as compared with the group receiving local 
treatment alone (P < 0.05). 
 
Conclusion: The experimental findings in the present study 
showed that adenovirus vectors Ad.Egr-wtp53-endostatin and 
Ad.CMV-sCAR-EGF in combination with local radiotherapy 
could improve the tumor control. These observations may set 
the stage for developing clinical protocols with recombinant 
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Purpose or Objective: One of the main effects of 
radiotherapy is the generation of free radicals as a 
consequence of the incidence of radiation on the aqueous 
molecules present in the cells. The enzyme D-aminoacid 
oxidase (DAO) is also able to generate free radicals when 
converting D-aminoacids in their corresponding cetoacids. 
Our principal aim is to increase radiotherapy effects, using 
